【HDL-C】High-density Lipoprotein Cholesterol Assay Kit (Direct Method-Selective Inhibition Method)

Background of Clinical Indications

It is used for the auxiliary diagnosis of cerebrovascular disease, diabetes, hepatitis and hepatic cirrhosis and other diseases. Increased: common in patients with primary hyperHDL (familial hyper-α-lipoproteinemia) and those receiving estrogen insulin or certain drugs (such as niacin, vitamin E, heparin, etc.); Decreased: common in patients with cerebrovascular disease, coronary heart disease, hypertriglyceridemia, and liver function damage. Its decrease can be used as a risk indicator of coronary heart disease.